SJ:NASDAQScienjoy Holding Corporation Analysis
Data as of 2026-09-05 - not real-time
$1.05
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Scienjoy Holding Corporation trades at $1.05, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has gained 29.1%. Relative strength is 58.7 — neutral — and the MACD signal is bullish. The recent range runs from support at $0.7770 up to resistance at $1.05.
Consensus targets land 93.0% above where the shares trade now. Revenue is contracting at 8.0% on a -46.8% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 86.2%, a beta of -0.25 and a maximum drawdown of 57.2%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Consensus targets land 93.0% above where the shares trade now. Revenue is contracting at 8.0% on a -46.8% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 86.2%, a beta of -0.25 and a maximum drawdown of 57.2%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
Benzinga.com4monScienjoy Holding Earnings & ForecastsScienjoy Holding SJ last issued guidance on November 25, 2024 for...2dScienjoy Holding Corporation to Acquire 29.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 1.02
- MACD momentum is positive
- 30-day price change of +29.1%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 1.02
- Analyst targets imply +93.0% versus the current price
- 30-day volatility of 86.2%
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -46.8%
- Analyst targets imply +93.0% versus the current price
- Negative return on equity of -64.7%
Key Metrics & Analysis
Financial Health
Revenue Growth-8.00%
Profit Margin-46.77%
ROE-64.71%
ROA-4.76%
Debt/Equity2.12
P/B Ratio0.5
Industry P/E15.5
Technical Analysis
TrendNeutral
RSI58.7
Support$0.78
Resistance$1.05
MA 20$0.95
MA 50$0.92
MA 200$1.02
MACDBullish
VolumeIncreasing
Fear & Greed Index95.48
Valuation
Target Price$2.02
Upside/Downside93.02%
GradeUndervalued
TypeBlend
Risk Assessment
Beta-0.25
Volatility86.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.